References
- Cartier L, Hartley O, Dubois-Dauphin M, et al. Chemokine receptors in the central nervous system: Role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev. 2005;48:16–42.
- Trebst C, Ransohoff RM. Investigating chemokines and chemokine receptors in patients with multiple sclerosis. Arch Neurol. 2001;58:1975–1980.
- Xia MQ, Qin SX, Wu LJ, et al. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer’s disease brains. Am J Pathol. 1998;153:31–37.
- van der Meer P, Ulrich AM, Gonzalez-Scarano F, et al. Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: Potential mechanisms for HIV dementia. Exp Mol Pathol. 2000;69:192–201.
- Wang X, Li X, Schmidt DB, et al. Identification and molecular characterization of rat CXCR3: Receptor expression and interferon-inducible protein-10 binding are increased in focal stroke. Mol Pharmacol. 2000;57:1190–1198.
- Hesselgesser J, Taub D, Baskar P, et al. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol. 1998;8:595–598.
- Cartier L, Dubois-Dauphin M, Hartley O, et al. Chemokine-induced cell death in CCR5-expressing neuroblastoma cells. J Neuroimmunol. 2003;145:27–39.
- Farber DB. From mice to men: The cyclic GMP phosphodiesterase gene in vision and disease. The Proctor Lecture. Invest Ophthalmol Vis Sci. 1995;36:263–275.
- Portera-Cailliau C, Sung CH, Nathans J, et al. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci U S A. 1994;91:974–978.
- Zeng HY, Zhu XA, Zhang C, et al. Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest Ophthalmol Vis Sci. 2005;46:2992–2999.
- Meucci O, Fatatis A, Simen AA, et al. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A. 1998;95:14500–14505.
- Tanabe S, Heesen M, Berman MA, et al. Murine astrocytes express a functional chemokine receptor. J Neurosci. 1997;17:6522–6528.
- Saeki T, Naya A. CCR1 chemokine receptor antagonist. Curr Pharmaceutical Design. 2003;9:1201–1208.
- Halks-Miller M, Schroeder ML, Haroutunian V, et al. CCR1 is an early and specific marker of Alzheimer’s disease. Ann Neurol. 2003;54:638–646.
- Wallace GR, Curnow JS, Wloka K, et al. The role of chemokines and their receptors in ocular diseases. Prog Retin Eye Res. 2004;23:435–448.
- Savarin-Vuaillat C, Ransohoff RM. Chemokines and chemokine receptors in neurological disease: Raise, retain, or reduce? Neurotherapeutics. 2007:4:590–601.
- Rottman JB, Slavin AJ, Silva R, et al. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur J Immunol. 2000;30:2372–2377.
- Liang M, Mallari C, Rosser M, et al. Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J Biol Chem. 2000;275:19000–19008.
- Kaul M, Lipton SA. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci U S A. 1999;96:8212–8216.
- Hadida F, Vieillard V, Mollet L, et al. Cutting edge: RANTES regulates Fas ligand expression and killing by HIV-specific CD8 cytotoxic T cells. J Immuno. 1999;163:105–109.
- Xia MQ, Hyman BT. Chemokine/chemokine receptors in the central nervous system and Alzheimer’s disease. J Neurovirol. 1999;5:32–41.